Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma.
Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma.
复制标题
DOI:
10.1093/hmg/ddr593
复制
发表时间:
2012-04-01
影响因子:
3.5
通讯作者:
Eng C
中科院分区:
文献类型:
--
作者:
Bebek G;Bennett KL;Funchain P;Campbell R;Seth R;Scharpf J;Burkey B;Eng C
Clinical observations and epidemiologic studies suggest that the incidence of head and neck squamous cell carcinoma (HNSCC) correlates with dental hygiene, implying a role for bacteria-induced inflammation in its pathogenesis. Here we begin to explore the pilot hypothesis that specific microbial populations may contribute to HNSCC pathogenesis via epigenetic modifications in inflammatory- and HNSCC-associated genes. Microbiomic profiling by 16S rRNA sequencing of matched tumor and adjacent normal tissue specimens in 42 individuals with HNSCC demonstrate a significant association of specific bacterial subpopulations with HNSCC over normal tissue (P < 0.01). Furthermore, microbial populations can separate tumors by tobacco status (P < 0.008), but not by alcohol status (P = 0.41). If our subhypothesis regarding a mechanistic link from microorganism to carcinogenesis via inflammation and consequent aberrant DNA methylation is correct, then we should see hypermethylation of relevant genes associate with specific microbiomic profiles. Methylation analysis in four genes (MDR1, IL8, RARB, TGFBR2) previously linked to HNSCC or inflammation shows significantly increased methylation in tumor samples compared with normal oral mucosa. Of these, MDR1 promoter methylation associates with specific microbiomic profiles in tumor over normal mucosa. Additionally, we report that MDR1 methylation correlates with regional nodal metastases in the context of two specific bacterial subpopulations, Enterobacteriaceae and Tenericutes (P < 0.001 for each). These associations may lead to a different, and potentially more comprehensive, perspective on the pathogenesis of HNSCC, and support further exploration of mechanistic linkage and, if so, novel therapeutic strategies such as demethylating agents and probiotic adjuncts, particularly for patients with advanced or refractory disease.
登录
查看更多内容
影响因子:
12.2
作者:
Shen XJ;Rawls JF;Randall T;Burcal L;Mpande CN;Jenkins N;Jovov B;Abdo Z;Sandler RS;Keku TO
通讯作者:
Keku TO
影响因子:
2.3
作者:
Bartsch, Helmut;Nair, Jagadeesan
通讯作者:
Nair, Jagadeesan
影响因子:
3.6
作者:
van der Deen, Margaretha;de Vries, Elisabeth G. E.;Timmer-Bosscha, Hetty
通讯作者:
Timmer-Bosscha, Hetty
DOI:
10.1007/978-1-60327-530-9_5
发表时间:
2009-01-01
期刊:
INFLAMMATION AND CANCER: METHODS AND PROTOCOLS, VOL 2: MOLECULAR ANALYSIS AND PATHWAYS
影响因子:
--
作者:
Suzuki, Hiromu;Toyota, Minoru;Shinomura, Yasuhisa
通讯作者:
Shinomura, Yasuhisa
影响因子:
5.8
作者:
van der Deen M;Timens W;Timmer-Bosscha H;van der Strate BW;Scheper RJ;Postma DS;de Vries EG;Kerstjens HA
通讯作者:
Kerstjens HA